During the last session, SBC Medical Group Holdings Inc (NASDAQ:SBC)’s traded shares were 99815.0, with the beta value of the company hitting 1.37. At the end of the trading day, the stock’s price was $4.65, reflecting an intraday gain of 2.65% or $0.12. The 52-week high for the SBC share is $19.50, that puts it down -319.35 from that peak though still a striking 43.66% gain since the share price plummeted to a 52-week low of $2.62. The company’s market capitalization is $481.79M, and the average intraday trading volume over the past 10 days was 85490.0 shares, and the average trade volume was 62.36K shares over the past three months.
SBC Medical Group Holdings Inc (NASDAQ:SBC) trade information
SBC Medical Group Holdings Inc (SBC) registered a 2.65% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 2.65% in intraday trading to $4.65, hitting a weekly high. The stock’s 5-day price performance is 0.22%, and it has moved by 36.36% in 30 days. Based on these gigs, the overall price performance for the year is -69.15%. The short interest in SBC Medical Group Holdings Inc (NASDAQ:SBC) is 78594.0 shares and it means that shorts have 0.82 day(s) to cover.
The consensus price target of analysts on Wall Street is $15, which implies an increase of 69.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $15 and $15 respectively. As a result, SBC is trading at a discount of -222.58% off the target high and -222.58% off the low.
While earnings are projected to return 20.83% in 2025.
SBC Dividends
SBC Medical Group Holdings Inc is due to release its next quarterly earnings on 2025-May-15. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
SBC Medical Group Holdings Inc (NASDAQ:SBC)’s Major holders
SBC Medical Group Holdings Inc insiders own 94.35% of total outstanding shares while institutional holders control 0.09%, with the float percentage being 1.63%.
